Cargando…

Editorial: Using omics to study leprosy, tuberculosis, and other mycobacterial diseases

Detalles Bibliográficos
Autores principales:	de Macedo, Cristiana Santos, Antunes, Luis Caetano Martha, Mohanty, Keshar Kunja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559580/ https://www.ncbi.nlm.nih.gov/pubmed/36250051 http://dx.doi.org/10.3389/fcimb.2022.1043635

Ejemplares similares

Using Omics to Study Leprosy, Tuberculosis, and Other Mycobacterial Diseases
por: Ahamad, Naseem, et al.
Publicado: (2022)

Editorial: Mycobacterial dormancy, culturability, and resuscitation: state-of-the-art, challenges, and future prospects
por: Salina, Elena G., et al.
Publicado: (2023)

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2022)

Editorial: The application of OMICS technologies to interrogate host-virus interactions
por: Gomes, Fabio, et al.
Publicado: (2022)

Editorial: Integrated omics approaches in the understanding of host-pathogen interactions
por: Al-Maleki, Anis Rageh, et al.
Publicado: (2023)

Editorial: “Omics”- revolution in elucidating the virulence and resistance in Staphylococcus aureus
por: Nurjadi, Dennis, et al.
Publicado: (2023)

Editorial: Protozoan parasites in the multi-omics era: present and future
por: Callejas-Hernández, Francisco, et al.
Publicado: (2023)

Editorial: Omics-based novel computational methods revealing microbe-disease associations
por: Yau, Stephen S.-T., et al.
Publicado: (2023)

Mycobacterium tuberculosis Rv0790c inhibits the cellular autophagy at its early stage and facilitates mycobacterial survival
por: Fang, Jun, et al.
Publicado: (2022)

Editorial: Pathogenic microbes: Multi-omics analysis of host-pathogen interactions and immune regulation
por: Wang, Xuanpeng, et al.
Publicado: (2022)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Editorial: New insights in Mycobacterium tuberculosis
por: Natarajaseenivasan, Kalimuthusamy
Publicado: (2022)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Editorial: Microbiome in the first 1000 days: multi-omic interactions, physiological effects, and clinical implications
por: Taddei, Carla R., et al.
Publicado: (2023)

CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival
por: Silveiro, Cátia, et al.
Publicado: (2023)

Editorial: Factors for the progression from latent tuberculosis infection to tuberculosis disease
por: Chen, Cheng, et al.
Publicado: (2023)

Diminished Systemic and Mycobacterial Antigen Specific Anti-microbial Peptide Responses in Low Body Mass Index–Latent Tuberculosis Co-morbidity
por: Rajamanickam, Anuradha, et al.
Publicado: (2020)

Editorial: Cellular and Molecular Mechanisms of Mycobacterium tuberculosis Virulence
por: Sun, Jianjun, et al.
Publicado: (2019)

Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?
por: Bajeli, Sapna, et al.
Publicado: (2020)

Airway epithelial cells mount an early response to mycobacterial infection
por: Barclay, Amy M., et al.
Publicado: (2023)

Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19
por: de Oliveira, Jéssica Araujo da Paixão, et al.
Publicado: (2022)

Gene expression patterns associated with multidrug therapy in multibacillary leprosy
por: Ferreira, Helen, et al.
Publicado: (2022)

Editorial: The relationship of oral and other body sites microbiome in human diseases
por: Xu, Tiansong, et al.
Publicado: (2023)

Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection
por: Silwal, Prashanta, et al.
Publicado: (2021)

Increased Interferon-Induced Protein With Tetracopeptides (IFITs) Reduces Mycobacterial Growth
por: Madhvi, Abhilasha, et al.
Publicado: (2022)

Editorial: Exosomes and exosomal miRNAs as biomarkers in infection with Mycobacterium tuberculosis
por: Alipoor, Shamila D.
Publicado: (2023)

Amidation of glutamate residues in mycobacterial peptidoglycan is essential for cell wall cross-linking
por: Shaku, Moagi T., et al.
Publicado: (2023)

Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections
por: Wang, Shilei, et al.
Publicado: (2023)

Lipid droplets as multifunctional organelles related to the mechanism of evasion during mycobacterial infection
por: de Almeida, Patrícia Elaine, et al.
Publicado: (2023)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis
por: Thirunavukkarasu, Shyamala, et al.
Publicado: (2019)

Performance evaluation and clinical validation of optimized nucleotide MALDI-TOF-MS for mycobacterial identification
por: Li, Baiying, et al.
Publicado: (2022)

DNA structural properties of DNA binding sites for 21 transcription factors in the mycobacterial genome
por: Dey, Upalabdha, et al.
Publicado: (2023)

Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs
por: Gu, Yuzhen, et al.
Publicado: (2023)

Mycobacterial Control of Host Mitochondria: Bioenergetic and Metabolic Changes Shaping Cell Fate and Infection Outcome
por: Mohareer, Krishnaveni, et al.
Publicado: (2020)

A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease
por: Ye, Fanghua, et al.
Publicado: (2022)

DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
por: Yu, Qian, et al.
Publicado: (2023)

A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis
por: Liang, Qiang, et al.
Publicado: (2023)

Editorial: Emerging concepts in Mycobacterium tuberculosis pathogenesis: Host-pathogen interaction and stress adaption mechanisms
por: Pandey, Saurabh, et al.
Publicado: (2023)

“It Takes Two to Tango”: Role of Neglected Macrophage Manipulators Coronin 1 and Protein Kinase G in Mycobacterial Pathogenesis
por: Saha, Saradindu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3g2g8o7d1v3akjep57o74m1e1k